Sinopep-Allsino Biopharmaceutical Co., Ltd. (Stock Code: 688076) is a Chinese innovation-driven company specializing in the development and manufacturing of peptide and oligonucleotide APIs and drug products. Listed on the Shanghai Stock Exchange, they operate as a full-service CDMO for complex peptide and oligonucleotide therapeutics. Their subsidiary Apextide Co., Ltd. is expanding with a large-scale manufacturing facility. The company has FDA-registered facilities with inspection history showing mostly compliant results.
peptide API synthesis and manufacturing, oligonucleotide manufacturing, GMP peptide CDMO, complex peptide therapeutics
1 site worldwide
No reviews available yet.
No documents available.